Annual Working Capital
$128.64 M
-$49.95 M-27.97%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual working capital is $128.64 million, with the most recent change of -$49.95 million (-27.97%) on December 31, 2023.
- During the last 3 years, ACHL annual working capital has fallen by -$42.54 million (-24.85%).
- ACHL annual working capital is now -51.57% below its all-time high of $265.64 million, reached on December 31, 2021.
Performance
ACHL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$93.16 M
-$10.37 M-10.01%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly working capital is $93.16 million, with the most recent change of -$10.37 million (-10.01%) on September 1, 2024.
- Over the past year, ACHL quarterly working capital has dropped by -$35.48 million (-27.58%).
- ACHL quarterly working capital is now -69.13% below its all-time high of $301.79 million, reached on June 30, 2021.
Performance
ACHL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ACHL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.0% | -27.6% |
| 3 y3 years | -24.9% | -48.1% |
| 5 y5 years | +29.7% | -48.1% |
ACHL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | at low | -64.9% | at low |
| 5 y | 5-year | -51.6% | +29.7% | -69.1% | at low |
| alltime | all time | -51.6% | +29.7% | -69.1% | at low |
Achilles Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $93.16 M(-10.0%) |
| Jun 2024 | - | $103.52 M(-12.1%) |
| Mar 2024 | - | $117.77 M(-8.4%) |
| Dec 2023 | $128.64 M(-28.0%) | $128.64 M(-6.3%) |
| Sep 2023 | - | $137.31 M(-12.0%) |
| Jun 2023 | - | $156.09 M(-6.7%) |
| Mar 2023 | - | $167.31 M(-6.3%) |
| Dec 2022 | $178.59 M | $178.59 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $179.63 M(-13.5%) |
| Jun 2022 | - | $207.71 M(-13.9%) |
| Mar 2022 | - | $241.20 M(-9.2%) |
| Dec 2021 | $265.64 M(+55.2%) | $265.64 M(-6.1%) |
| Sep 2021 | - | $282.91 M(-6.3%) |
| Jun 2021 | - | $301.79 M(+90.7%) |
| Mar 2021 | - | $158.26 M(-7.5%) |
| Dec 2020 | $171.17 M(+72.5%) | $171.17 M |
| Dec 2019 | $99.20 M | - |
FAQ
- What is Achilles Therapeutics annual working capital?
- What is the all time high annual working capital for Achilles Therapeutics?
- What is Achilles Therapeutics annual working capital year-on-year change?
- What is Achilles Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly working capital year-on-year change?
What is Achilles Therapeutics annual working capital?
The current annual working capital of ACHL is $128.64 M
What is the all time high annual working capital for Achilles Therapeutics?
Achilles Therapeutics all-time high annual working capital is $265.64 M
What is Achilles Therapeutics annual working capital year-on-year change?
Over the past year, ACHL annual working capital has changed by -$49.95 M (-27.97%)
What is Achilles Therapeutics quarterly working capital?
The current quarterly working capital of ACHL is $93.16 M
What is the all time high quarterly working capital for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly working capital is $301.79 M
What is Achilles Therapeutics quarterly working capital year-on-year change?
Over the past year, ACHL quarterly working capital has changed by -$35.48 M (-27.58%)